ISRCTN07607027已完成未知
Promoting adherence to a regimen of risk factor modification by trained non-medical personnel evaluated against regular practice: a open-label randomised controlled trial
ondon Health Sciences Centre (Canada)0 个研究点目标入组 316 人开始时间: 2009年3月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 316
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Subjects aged 18 years or greater, either sex, who:
- •1. Experienced transient ischaemic attack or non-disabling stroke within 90 days of randomisation
- •2. Have hypertension
排除标准
- •1. Neuroimaging studies suggest other causes for presenting event (e.g., primary intracerebral haemorrhage, tumour, etc.)
- •2. Unable to communicate in English or French, or severe aphasia
- •3. Moderate to severe disability with modified Rankin Scale score greater than or equal to 3
- •4. Known dementia
- •5. Severe concomitant medical conditions with life expectancy of less than two years
- •6. Unable or unwilling to return for study-related scheduled follow-ups
- •7. Concurrent participation in other interventional studies
研究者
相似试验
尚未招募
不适用
Medication adherence and management of risk factors for secondary stroke preventioCTRI/2022/06/042980World Stroke Organization
已完成
不适用
Individual Risk Awareness Intervention in StrokeCirculatory SystemStroke, not specified as haemorrhage or infarctionStrokeISRCTN67999605Imperial College London (UK)238
招募中
不适用
Intervention to prevent factors that can lead to the development of Eating Disorders and to increase positive body image factors, such as self-esteem, acceptance and respect for the body and a more intuitive dietEating Disorders and Food IntakeF03.400RBR-2f57csniversidade Federal de Juiz de Fora - Campus Governador Valadares
招募中
不适用
Individualized Prevention Strategy for High Risk Patients in Cardiovascular DiseaseDiseases of the circulatory systemKCT0001106Yonsei University Health System, Severance Hospital4,000
尚未招募
不适用
Improvement of the Patientenadherence and avoidance of side effects by one special speech hour for oral tumour therapyD47.4C90.0PATIENTENADHERENCE QUALITY OF LIFE CURVESTOXICITYCURVE NCI CTC Version 4.0 HOSPITALISATIONS DOCTOR'S CONTACTSC18C19C20C50C34C64C43C83.1C91.1C82D45C92.1Malignant neoplasm of colonMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of rectumMalignant neoplasm of breastMalignant neoplasm of bronchus and lungMalignant neoplasm of kidney, except renal pelvisMalignant melanoma of skinChronic lymphocytic leukaemia of B-cell typeOsteomyelofibrosisPolycythaemia veraChronic myeloid leukaemia [CML], BCR/ABL-positiveFollicular lymphomaMantle cell lymphomaMultiple myelomaDRKS00010797Onkologisch-palliativmedizinisches Netzwerk Landshut100